Hims & Hers Health Inc (NYSE: HIMS) started the day on Thursday, with a price decrease of -3.39% at $66.41, before settling in for the price of $68.74 at the close. Taking a more long-term approach, HIMS posted a 52-week range of $9.22-$72.98.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Consumer Defensive sector posted annual sales growth of 60.52% over the last 5 years. Nevertheless, stock’s Earnings Per Share (EPS) this year is 590.70%. This publicly-traded company’s shares outstanding now amounts to $209.44 million, simultaneously with a float of $178.10 million. The organization now has a market capitalization sitting at $14.51 billion. At the time of writing, stock’s 50-day Moving Average stood at $34.51, while the 200-day Moving Average is $23.46.
Hims & Hers Health Inc (HIMS) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Household & Personal Products Industry. Hims & Hers Health Inc’s current insider ownership accounts for 18.48%, in contrast to 74.94% institutional ownership. According to the most recent insider trade that took place on Feb 18 ’25, this organization’s Chief Executive Officer sold 128,127 shares at the rate of 58.27, making the entire transaction reach 7,466,121 in total value, affecting insider ownership by 97,687. Preceding that transaction, on Feb 18 ’25, Company’s Chief Executive Officer sold 47,534 for 58.15, making the whole transaction’s value amount to 2,763,942. This particular insider is now the holder of 427,796 in total.
Hims & Hers Health Inc (HIMS) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.22 per share during the current fiscal year.
Hims & Hers Health Inc’s EPS increase for this current 12-month fiscal period is 590.70% and is forecasted to reach 0.54 in the upcoming year.
Hims & Hers Health Inc (NYSE: HIMS) Trading Performance Indicators
Let’s observe the current performance indicators for Hims & Hers Health Inc (HIMS). It’s Quick Ratio in the last reported quarter now stands at 1.82. The Stock has managed to achieve an average true range (ATR) of 5.01. Alongside those numbers, its PE Ratio stands at $153.62, and its Beta score is 1.42. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 11.68. Similarly, its price to free cash flow for trailing twelve months is now 96.97.
In the same vein, HIMS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.43, a figure that is expected to reach -0.00 in the next quarter, and analysts are predicting that it will be 0.54 at the market close of one year from today.
Technical Analysis of Hims & Hers Health Inc (HIMS)
If we take a close look at the recent performances of Hims & Hers Health Inc (NYSE: HIMS), its last 5-days Average volume was 38.61 million that shows progress from its year to date volume of 15.82 million. During the previous 9 days, stock’s Stochastic %D was recorded 80.63% While, its Average True Range was 6.04.
Raw Stochastic average of Hims & Hers Health Inc (HIMS) in the period of the previous 100 days is set at 88.46%, which indicates a major rise in contrast to 83.28% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 118.91% that was higher than 112.15% volatility it exhibited in the past 100-days period.
